Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Future Oncol. 2021 Jan;17(1):37-44. doi: 10.2217/fon-2020-0497. Epub 2020 Dec 2.
We incorporated questions related to safety, effectiveness and other characteristics of systemic cancer treatment into a self-report questionnaire - the Therapy Preference Scale - that captures patients´ preferences. The authors asked 20 experts to assess content validity and an additional 20 experts, patients and community members to examine face validity and guide revisions. Key revisions included shortening the length, clarifying constructs and providing details to explain the context and trade-offs necessary to balance the risks and benefits of cancer treatment. The content validity index for the final questionnaire was 1.0, indicating that all questions were relevant. Reviewers expressed that the questionnaire would serve an important purpose. Experts, patients and community members guided revisions of the questionnaire and documented its value.
我们将与癌症系统治疗的安全性、有效性和其他特征相关的问题纳入到一个自报告问卷中——治疗偏好量表——以捕捉患者的偏好。作者请 20 名专家评估内容效度,另外请 20 名专家、患者和社区成员评估表面效度,并指导修订。主要修订包括缩短长度、澄清概念,并提供详细信息,以解释在权衡癌症治疗的风险和收益时所需的背景和取舍。最终问卷的内容效度指数为 1.0,表明所有问题都是相关的。评论者表示,该问卷将有重要的用途。专家、患者和社区成员指导了问卷的修订,并记录了其价值。